Target intelligence / Profile preview

Populus alba pollen allergen Pop a 1 (Pop a 1)

Target
Pop a 1
Molecular classification
PR-10 protein family, Allergen
01

Overview

Populus alba pollen allergen Pop a 1 is the primary allergenic protein identified in the pollen of the white poplar tree. It belongs to the pathogenesis-related protein family 10 (PR-10), which is characterized by a conserved fold capable of binding various hydrophobic ligands (WHO/IUIS Allergen Nomenclature, 2023). In sensitized individuals, this allergen is captured by antigen-presenting cells (APCs), such as dendritic cells, through receptor-mediated endocytosis or fluid-phase pinocytosis (Bohle, 2007). Following uptake, the allergen is proteolytically processed into peptides and presented on MHC class II molecules to CD4+ T cells, driving a Th2-polarized immune response. This cascade results in the production of allergen-specific IgE antibodies, leading to clinical conditions such as seasonal allergic rhinitis and asthma upon re-exposure (D'Amato et al., 2007). While not a traditional therapeutic target, Pop a 1 is the active component in allergen-specific immunotherapy (AIT), which aims to induce immunological tolerance. AIT modifies the immune response by promoting regulatory T cell activity and shifting the cytokine profile away from an allergic state (Bousquet et al., 1998). Understanding the interaction between Pop a 1 and APCs is critical for the development of targeted desensitization strategies.

Other names
Pop a 1White poplar allergenPR-10 protein Pop a 1Populus alba major pollen allergen
02

Mechanism of action

Allergen immunotherapy (AIT) induces immune tolerance by promoting regulatory T cell (Treg) activity and shifting the immune response from Th2 to Th1 (Bousquet et al., 1998).

03

Biological functions

Immune responseAntigen presentationAllergen uptakeT cell activation
04

Disease associations

Allergic rhinitisAsthmaPollinosisInflammation
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal site reactions during immunotherapy
06

Interacting drugs

Allergen immunotherapy

3 more in the full profile.

07

Biomarkers

Specific IgE (sIgE) to Pop a 1Skin prick test (SPT) reactivityBasophil activation test (BAT)

Beyond the preview

Go deeper on Populus alba pollen allergen Pop a 1 (Pop a 1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Populus alba pollen allergen Pop a 1 (Pop a 1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call